INOPASE Inc. is a medical device company focusing on developing miniaturized closed-loop neuromodulation to cure neurological disease for better treatment, such as Epilepsy, Urinary Incontinence and Faecal Incontinence, which is different from conventional neuromodulation that only achieved symptom reduction. We have a patented wireless charging technology and closed-loop technology.
The closed-loop technology is a personalized treatment because the treatment effect (Nerve stimulation) is automatically regulated based on each patient’s nerve monitoring. This approach can achieve higher treatment outcome and patient comfort.

INOPASE has two product pipelines: Closed-loop Sacral Neuromodulation and Closed-loop Brain Neuromodulation.
Closed-loop Sacral Neuromodulation: We are developing the world only smallest and smartest implant device to cure Urinary Incontinence and Faecal Incontinence. Sacral Neuromodulation market is forecasted to reach 2.4 billion USD global market by 2026. INOPASE aims to launch the product in 2026 and forecasts to reach 300 million USD sales by 2030.

Closed-loop Brain Neuromodulation: We are developing the world only full brain electrode coverage (128 & 256 electrodes) and thinnest electrode (10µm thickness) to treat Epilepsy. The brain neuromodulation is forecasted to reach 3.4 billion USD by 2027.

OUI Inc. is a University-launched startup founded by the ophthalmologists. Nowadays, over 44 million people are blind and 2 billion populations has a visual impairment, and the economic loss is calculated over 5 trillion USD. The main cause of this world blindness can be treatable by sufficient diagnosis and treatment. However, due to the lack of medical devices, these numbers are gaining these days. To solve this word problem, we invented a smartphone attachment medical device named “Smart Eye Camera(SEC)” which has an equal function as a conventional slit-lamp microscope. SEC achieved to perform an ophthalmology diagnosis anywhere, anyone, and anytime. SEC has great potential in remote diagnosis and online consultation especially in developing countries in isolated places. Moreover, we are developing diagnostic artificial intelligence (AI) to develop a new style of ophthalmology diagnostic system. We just started this project in 2021, now we have over 20 partners, and over 100 SECs are installed worldwide to bring an ophthalmology diagnosis, especially in Africa, Southeast Asia, and Latin America to screen out the treatable eye disease and bring them to suitable ophthalmology partners. We aimed to reduce 50% of the world’s blindness by expanding SEC.

We aim for a society where people can do what they want as long as they wish to continue, which might be work, daily life or hobby.

Qolo is a University-originated startup with a core technology that enables people to stand up even if they have limited lower limb motor ability.

Being seated long time would cause functional problems such as you cannot reaching your hands and eyes to higher places as well as health problems.
Health problems, including pressure sore, bone demineralization and circular system, would shorten the length of a healthy life.

Qolo cares wide range of their journey which starts from wheelchair to back to life.
We support rehabilitation first, then back up their daily life later.
Rehabilitation products make standing rehabilitation efficient and encourage the improvement of motor function without physical overload on therapists.
Mobility products enable them to stand up and move in daily life scenes even if they could not recover enough.

We develop those models parallel and make it Japanese market available in 2023, then 2026 in the US.
We do update quickly our product in Japan first since both models are not considered medical devices.

Redge, Inc. aims to provide sustainable and safe medical care to all over the world with clinical engineer technology. Medical devices are essential equipment for treating the patient in a hospital. However, the medical device failures are frequently happened in developing countries, resulting medical accidents and threatened patient’s lives. It is cause of lack of maintenance and education of medical devices in local area. In Japan, clinical engineer, national license is dealing with medical device to maintain high quality medicine. Therefore, Redge, Inc. provides “CeTrax”, packaging system including medical device management and education based on Japanese clinical engineer knowledge and experience. For management part, we provide a simple system that combines cloud database computing and AI image recognition. It leads to forecast medical device failure and balance supply & demand consumable parts based on prediction the working rate of medical device. For education part, combination of hands-on training and video contents will expand local medical provider resources. CeTrax will improve the quality and safety of medical devices in developing countries.

Nervotec is the world’s first provider of HaaS (Healthcare as a Service), a software only solution that measures and analyses physiological biomarkers remotely and contactlessly across multiple mobile platforms.

Nervotec’s proprietary video-based technology enables the rapid measurement of physiological biomarkers with medical grade accuracies, while creating actionable insights on stress and heart health.

Nervotec’s solutions are used in professional sports, construction, insurance, healthcare, and governmental sectors worldwide.

Through its technologies, Nervotec is transforming the way people access healthcare, truly enabling healthcare anywhere.

Humetrics focuses on elderly and respiratory care, and was founded in July 2020 with 6 team members. Our first product is the iCue smart mat. It is used to be placed underneath the mattress and to measure the minor vital signs of the users lying on top of it.

iCue provides real-time caring information, including the bed-exit notice, bedridden, respiration rate, and sleep report, and has been demonstrated to increase the efficiency of the caregiver in the nursing home. It is also proven to reduce fall risk by 60%.

Until now, more than 1,200 beds are distributed in the caring facilities and help care for the elderly. Besides the real-time caring information, iCue has been experimentally proven to measure abdominal breath profile with the benchmark of polysomnography (PSG).

This new feature helps to cover more detail of the breath information. This caught the interest and successfully introduced the installation in higher intensive facilities.

Besides the local market, Humetrics is also introducing the product to Japan. Beta-site testing is undergoing in Zenkoukai, and more than two Japanese distributors are engaging in the Japanese market initiative.

RealBone® Technology Co. Ltd. has developed a new surface modification technology for calcium phosphate powder which obtained a Taiwan invention patent (Cert. No.: I427050) and Japan patent (JPN: 5280403).
The technology improves the physicochemical properties of the derived biomedical ceramics by increasing the linkages between the particles to allow crystal growth. Accordingly, we have developed an excellent product “REALBONE” resorbable calcium phosphate bone graft substitute (injectable).

Compared with other products, it not only has better operability, but also has good injectability and disintegration resistance. The initial setting time is 9 minutes, and compressive strength is 18-24MPa. It can be applied to various surgical operations that require strength, even under load-bearing conditions. This product has obtained the Class II medical device license from Food and Drug Administration of Taiwan in 2021. It has passed the trial procedure and has won the tender from Taipei Veterans General Hospital, and is waiting for tender at National Taiwan University Hospital. As a result, the product has flourished due to its wide range of applications to accelerate healing and thus improve the quality of life. Just like RealBone® Tech. slogans “REALBONE, Reborn all your bone & are those who make others’ Real Bone healthy”.

Peth Yoeung by First Womentech Asia Co., Ltd. is a Cambodia’s largest cloud-based Hospital Management Software Platform created to advance our healthcare ecosystem in Cambodia and ASEAN nations through securing medical records, patient data and smoothening hospital operating processes and is also integrated with a premier healthcare marketplace to help improving the pathway to access to healthcare of people anywhere, anytime conveniently. Peth Yoeung has set strong footprint in Cambodia and is recognized by the Ministry of Health of Cambodia. Peth Yoeung won national competition as the social start-up business to join the international competition in Geneva, Switzerland 2019 (distance) and award from the Ministry of Post and Telecommunications last March 2019.

It has been deployed for nearly 200 public and private hospitals and clinics—covering 15 provinces and Phnom Penh, Cambodia. Nearly 10k active users of combined medical doctors, nurses, pharmacists, lab technicians, health professionals and hospital related administrative staffs signed up with Peth Yoeung. We have been making positive impact on the life and healthcare of nearly 2 million Cambodian population and have made millions of medical records available and accessible online anywhere, anytime for better healthcare and treatment.